UCB Pharma GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1946-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.ucb.de
Clinical Trials
5
Active:0
Completed:5
Trial Phases
0 Phases
Drug Approvals
3
NMPA:2
PHILIPPINES:1
Drug Approvals
Clinical Trials
Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy
Completed
- Conditions
- Focal Epilepsy With and Without Secondary Generalization
- Interventions
- First Posted Date
- 2012-08-27
- Last Posted Date
- 2016-11-15
- Lead Sponsor
- UCB Pharma GmbH
- Target Recruit Count
- 315
- Registration Number
- NCT01673282
- Locations
- 🇦🇹
60, Innsbruck, Austria
🇦🇹61, Mauer bei Amstetten, Austria
🇦🇹63, Ried, Austria
Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease
Completed
- Conditions
- Idiopathic Parkinson's Disease
- First Posted Date
- 2012-05-28
- Last Posted Date
- 2018-04-04
- Lead Sponsor
- UCB Pharma GmbH
- Target Recruit Count
- 93
- Registration Number
- NCT01606670
- Locations
- 🇦🇹
61, Feldbach, Austria
🇦🇹60, Linz, Austria
🇩🇪16, Altenholz, Germany
Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal Patch
Completed
- Conditions
- Idiopathic Parkinson's Disease
- First Posted Date
- 2010-07-09
- Last Posted Date
- 2013-05-21
- Lead Sponsor
- UCB Pharma GmbH
- Target Recruit Count
- 76
- Registration Number
- NCT01159691
- Locations
- 🇩🇪
02, Berlin, Germany
🇩🇪24, Bochum, Germany
🇩🇪38, Buchholz, Germany
Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug
Completed
- Conditions
- Epilepsies, Partial
- First Posted Date
- 2010-04-02
- Last Posted Date
- 2014-09-03
- Lead Sponsor
- UCB Pharma GmbH
- Target Recruit Count
- 576
- Registration Number
- NCT01098162
- Locations
- 🇩🇪
55, Aachen, Germany
🇩🇪119, Aalen, Germany
🇩🇪194, Aichach, Germany
Observation of Treatment With Certolizumab Pegol in Daily Practice
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2015-10-29
- Lead Sponsor
- UCB Pharma GmbH
- Target Recruit Count
- 1117
- Registration Number
- NCT01069419
- Locations
- 🇩🇪
174, Altenburg, Germany
🇩🇪70, Amberg, Germany
🇩🇪122, Attendorn, Germany
News
No news found